XERIS BIOPHARMA HOLDINGS INC (XERS) Stock News
NASDAQ:XERS - Nasdaq - US98422E1038 - Common Stock - Currency: USD
XERS Latest News, Press Relases and Analysis
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) – A Strong Growth Candidate Meeting Minervini’s Criteria
XERIS Biopharma (XERS) meets Minervini’s Trend Template with strong technicals and high growth momentum, including 47.9% quarterly revenue growth and a 93.95 Relative Strength score.
Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day
Xeris Announces Details for Analyst & Investor Day
Xeris Biopharma Holdings, Inc. (XERS): Among the Unstoppable Growth Stocks to Invest in Now
We recently published a list of 11 Unstoppable Growth Stocks to Invest in Now. In this article, we are going to take a look at where Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) stands against other unstoppable growth stocks to invest in now. BlackRock highlighted that the trade conflict between the US and China continues to cause major […]
Xeris Biopharma (XERS) Reports Q1 Loss, Tops Revenue Estimates
Xeris Biopharma (XERS) delivered earnings and revenue surprises of 14.29% and 4.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ZVRA
Xeris Biopharma Reports Record First Quarter 2025 Financial Results
Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates
Corcept (CORT) delivered earnings and revenue surprises of 0% and 11.66%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: CORT
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Personalis, Inc. (NASDAQ:PSNL) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to some of […]
Is Fubotv Inc. (FUBO) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Fubotv Inc. (NYSE:FUBO) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to some of […]
Is CommScope Holding Company, Inc. (COMM) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where CommScope Holding Company, Inc. (NASDAQ:COMM) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to […]
Is Lumen Technologies, Inc. (LUMN) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Lumen Technologies, Inc. (NYSE:LUMN) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to some […]
Jim Cramer on CVS Health (CVS): “CVS Is the Best… the Last One Standing”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer […]
GraniteShares Launches New Leveraged, Single-Stock EV ETFs
- GraniteShares just introduced two leveraged single-stock ETFs. - The new ETFs are focused on EV-makers Lucid Group and Rivian Automotive. - The expense ratio is 1.15% for both funds.
Jim Cramer on Shopify (SHOP): “De Minimis Will Sort Itself Out”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where Shopify Inc. (NASDAQ:SHOP) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed […]
Jim Cramer on CSX Corp (CSX): “There Is an Element of Forgiveness Today”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where CSX Corporation (NASDAQ:CSX) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed […]
Plug Power Inc. (PLUG): Among EV Penny Stock From $10 to Under $1
We recently published a list of EV Penny Stocks List: From $10 to Under $1. In this article, we are going to take a look at where Plug Power Inc. (NASDAQ:PLUG) stands against other stocks in EV penny list: from $10 to under $1. The global electric vehicle (EV) market is on a roll despite […]
3 No-Brainer EV Stocks to Buy With $100 Right Now
ChargePoint, Nio, and Archer Aviation are high-risk, high-reward plays.
NVIDIA Corporation (NVDA): Among Stocks That Could 10X Over the Next 2 Years
We recently published a list of 9 Stocks That Could 10X Over the Next 2 Years. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other stocks that could 10X over the next 2 years. US Tariffs and the Stock Market Turmoil While tariffs from the US […]
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
Xeris Announces Changes to Its Board of Directors
Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid
Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025
Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer
Xeris to Participate in Upcoming Investor Conferences
The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness
/PRNewswire/ -- The American Diabetes Association® (ADA) and Xeris Pharmaceuticals® (Xeris BioPharma Holdings, Inc.), a national supporter of the ADA, are...
Xeris Expects to Exceed Full-Year 2024 Financial Guidance
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
